Merck & Co Inc (6MK) Stock Price & News

Merck & Co., Inc. is an American multinational pharmaceutical company headquartered in Rahway, New Jersey. The company does business as Merck Sharp & Dohme or MSD outside the United States and Canada. The company is ranked fifth on the list of largest biomedical companies by revenue. The company's revenues are primarily from cancer treatments, vaccines, and animal health products. In 2024, 46% of the company's revenue, or $29.5 billion, came from sales of Keytruda, a PD-1 inhibitor used to treat various types of cancers, and 13% of the company's revenue, or $8.6 billion, came from sales of Gardasil, an HPV vaccine. In addition, 9% of the company's revenue, or $5.8 billion, came from the sales of animal health products. The company is ranked 65th on the Fortune 500 and 76th on the Forbes Global 2000. In 1891, Merck & Co. was established as the American affiliate of the Merck Group, founded by the Merck family, and the companies are still in trademark disputes in several countries over the right to use the name "Merck". Wikipedia

About Merck & Co Inc

CEORobert M Davis

Employees74 мян

Founded1891 оны 1-р сарын 1

Headquarters-

SectorPharmaceutical industry

Websitemerck.com

All values in USD	2025 оны 9-р сар	2025 оны 12-р сар	2026 оны 3-р сар	2026 оны 6-р сар
Revenue	17.28 тэрбум	16.40 тэрбум	16.29 тэрбум	16.61 тэрбум
Cost of goods sold	3.74 тэрбум	4.30 тэрбум	3.88 тэрбум	4.13 тэрбум
Cost of revenue	3.74 тэрбум	4.30 тэрбум	3.88 тэрбум	4.13 тэрбум
Research and development expenses	4.00 тэрбум	4.00 тэрбум	3.56 тэрбум	9.74 тэрбум
Total research and development expenses	-	-	-	-
Selling, general, and admin expenses	2.48 тэрбум	2.73 тэрбум	2.57 тэрбум	2.78 тэрбум
Operating expense	6.48 тэрбум	6.73 тэрбум	6.12 тэрбум	12.52 тэрбум
Total operating expenses	10.23 тэрбум	11.02 тэрбум	10.00 тэрбум	16.65 тэрбум
Operating income	7.05 тэрбум	5.38 тэрбум	6.29 тэрбум	-40.00 сая
Other non operating income	-	41.00 сая	42.00 сая	59.00 сая
EBT including unusual items	6.74 тэрбум	3.42 тэрбум	-3.53 тэрбум	-683.00 сая
EBT excluding unusual items	6.76 тэрбум	4.98 тэрбум	5.85 тэрбум	-508.00 сая
Income tax expense	958.00 сая	458.00 сая	709.00 сая	654.00 сая
Effective tax rate	14.20%	13.39%	-20.06%	-95.75%
Other operating expenses	-	-	-	-
Net income	5.78 тэрбум	2.96 тэрбум	-4.24 тэрбум	-1.34 тэрбум
Net profit margin	33.49%	18.07%	-26.03%	-8.04%
Earnings per share	2.58	2.04	-1.28	-0.13
Interest and investment income	96.00 сая	69.00 сая	35.00 сая	35.00 сая
Interest expense	-327.00 сая	-411.00 сая	-479.00 сая	-525.00 сая
Net interest expenses	-231.00 сая	-342.00 сая	-444.00 сая	-490.00 сая
Depreciation and amortization charges	-	-	-	-
EBITDA	8.15 тэрбум	6.79 тэрбум	7.69 тэрбум	1.43 тэрбум
Gain or loss from assets sale	-	-	-	-

Ask anything